Citation

84 FR 12966

Canonical document for this Federal Register citation.

The Future of Insulin Biosimilars: Increasing Access and Facilitating the Efficient Development of Biosimilar and Interchangeable Insulin Products; Public Hearing; Request for Comments Wednesday, April 3, 2019 84 FR 12966